Novozymes A/S
LSE:0Q4U
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novozymes A/S
LSE:0Q4U
|
DK |
|
T
|
Takkt AG
XBER:TTK
|
DE |
|
F
|
Fairfax Financial Holdings Ltd
BMV:FFHN
|
CA |
|
E
|
Electricite de France SA
XHAM:E2F
|
FR |
|
Beiersdorf AG
XETRA:BEI
|
DE |
|
AstraZeneca PLC
LSE:AZN
|
UK |
|
Verizon Communications Inc
NYSE:VZ
|
US |
Wall St Price Targets
0Q4U Price Targets Summary
Novozymes A/S
According to Wall Street analysts, the average 1-year price target for 0Q4U is 473.66 DKK with a low forecast of 383.43 DKK and a high forecast of 579.05 DKK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0Q4U's stock price target?
Price Target
473.66
DKK
According to Wall Street analysts, the average 1-year price target for 0Q4U is 473.66 DKK with a low forecast of 383.43 DKK and a high forecast of 579.05 DKK.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
